Xtandi 80 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FWQV7
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,170
Award facts
- Contract value 100% obligated
- $4,169.59 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $4,169.59 delivery order to DMS Pharmaceutical Group Inc. on September 5, 2025, for the supply of Xtandi 80 mg tablets (60-count units). This firm fixed-price delivery order, designated 4569340914, is scheduled for completion by September 8, 2025, and will be performed at the vendor's facility in Park Ridge, Illinois. The contract carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on an open basis despite its status as a woman-owned small business.
DMS Pharmaceutical Group, a pharmaceutical wholesaler based in Illinois and registered in the System for Award Management since 2001, operates as a key supplier within the Defense Logistics Agency's pharmaceutical supply chain. This delivery order is issued under the vendor's larger Indefinite Delivery Contract (IDC) with DLA valued at $499,999,999 through November 2026, which enables the agency to procure a comprehensive portfolio of pharmaceutical products supporting Department of Defense healthcare facilities worldwide. The company specializes in distributing branded and generic prescription drugs, biologics, and medical consumables to military and federal healthcare systems, with Xtandi—an oncology medication—representing one of numerous specialized pharmaceutical products within its federal contract portfolio.
Quick answers
Who was awarded contract SPE2DB25FWQV7?
SPE2DB25FWQV7 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 5, 2025.
How much is contract SPE2DB25FWQV7 worth?
The government has obligated $4,170 on SPE2DB25FWQV7.
Is contract SPE2DB25FWQV7 an order under another contract?
Yes. SPE2DB25FWQV7 is a delivery order under SPE2DB24D9218, an indefinite delivery contract.
Was contract SPE2DB25FWQV7 competed?
The extent of competition for SPE2DB25FWQV7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award